This interview is focused on usage of AI in Longevity

This video is besed on how AI will change treatment planning, radiation oncology and medical imaging.

In this video is exploration how we can use AI in Drug Discovery and Limitations which it has.

In this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about Watson AI and what it can offer to healthcare providers and patients who have diabetes and are taking diabetes medications.

Explanation of how AI can help us understand depression better and improve treatment options.

In an exclusive interview with Euronews Next at Cannes Lions, Moderna's chief brand officer sets out why artificial intelligence has been so valuable.

In this Zoom-recorded interview from 10th February 2021, the project's scientific coordinator, Prof. Dr. Jan Baumbach from the University of Hamburg in Germany, explains how FeatureCloud's federated and privacy-aware machine learning approach can make all sides happy - clinicians, biomedical researchers, and, most importantly, patients.

Sarah Fremond, Leiden University Medical Centre, Leiden, The Netherlands, comments on the field of artificial intelligence (AI) discussed at AACR 2023, highlighting how although some AI model predictions may not be able to be validated focus should be directed towards the production of tools to decipher whether the models prediction is confident.

Margot Jak, MD, University Medical Center Utrecht, Utrecht, The Netherlands, describes a project using AI to analyze PET/CT data from the JULIET trial (NCT02445248) and identify patients with relapsed/refractory diffuse large B-cell lymphoma that will respond to CAR-T cell therapy.

The interview is focused on current and future solutions to digital tools within the mental health field.

Jaxson Khan sits down with Professor Samuel Aparicio, the Chair in Breast Cancer Research at the University of British Columbia (UBC) and Head of the BC Cancer Research Institute Department of Breast and Molecular Oncology to ask the question: How is artificial intelligence being used to help predict breast cancer?

Dr. Calderaro, Associate Professor of Pathology at Henri Mondor Hospital in Paris, France, speaks about collaborating with Owkin using ML to evaluate survival prediction with hepatocellular carcinoma (the most common type of primary liver cancer).